A closer look at how local protein production is altered in ALS

The functioning of neurons, cells that transmit information in the nervous system, heavily relies on the production of ...
pharmaphorum

Four more drugs in keenly watched ALS trial miss the mark

Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 HEALEY ALS basket trial, which is trying to accelerate the search for new ...
pharmaphorum

Biogen gets FDA approval for ALS drug Qalsody

After much deliberation, the FDA has granted accelerated approval for Biogen’s tofersen for an ultra-rare form of the neurodegenerative disease amyotrophic lateral sclerosis, associated with a ...